Literature DB >> 2109530

Enhancement of sickle erythrocyte adherence to endothelium by autologous platelets.

R Antonucci1, R Walker, J Herion, E Orringer.   

Abstract

The increased adhesiveness of sickle erythrocytes (SS RBC) to endothelial cells has been confirmed in a static system utilizing fresh umbilical vein endothelium. Adherence of SS RBC to the endothelium was as great in the presence of calcium-containing buffer as when incubated in plasma. SS RBC suspended in autologous platelet-rich plasma adhered to a greater extent than when suspended in autologous platelet poor plasma. Prostacyclin, thromboxane B2, and an inhibitor of collagen- and epinephrine-induced platelet aggregation (B13.177) did not affect SS RBC adherence to endothelium. Aspirin in a concentration of 5 micrograms/ml slightly decreased SS RBC adherence to endothelium in the presence of platelets. Platelets may play a significant role in the increased adhesiveness of SS RBC to endothelium. To the extent that increased SS RBC adhesiveness contributes to the genesis of painful crises and to the extent platelets augment this adhesiveness, agents affecting platelet function may prove useful in preventing painful crises.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2109530     DOI: 10.1002/ajh.2830340110

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  5 in total

1.  Plasma thrombospondin-1 is increased during acute sickle cell vaso-occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates.

Authors:  Enrico M Novelli; Gregory J Kato; Margaret V Ragni; Yingze Zhang; Mariana E Hildesheim; Mehdi Nouraie; Suchitra Barge; Michael P Meyer; Andrea Cortese Hassett; Victor R Gordeuk; Mark T Gladwin; Jeffrey S Isenberg
Journal:  Am J Hematol       Date:  2012-02-08       Impact factor: 10.047

2.  Platelet bioenergetic screen in sickle cell patients reveals mitochondrial complex V inhibition, which contributes to platelet activation.

Authors:  Nayra Cardenes; Catherine Corey; Lisa Geary; Shilpa Jain; Sergey Zharikov; Suchitra Barge; Enrico M Novelli; Sruti Shiva
Journal:  Blood       Date:  2014-03-27       Impact factor: 22.113

3.  Risk factors for increased ED utilization in a multinational cohort of children with sickle cell disease.

Authors:  Jeffrey A Glassberg; Jason Wang; Robyn Cohen; Lynne D Richardson; Michael R DeBaun
Journal:  Acad Emerg Med       Date:  2012-06       Impact factor: 3.451

4.  Clinical significance of assessment of thrombospondin and placenta growth factor levels in patients with sickle cell anemia: two centers egyptian studies.

Authors:  Adel A Hagag; Ghada Elmashad; Aml Ezzat Abd El-Lateef
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-07-01       Impact factor: 2.576

5.  Expression of regulatory platelet microRNAs in patients with sickle cell disease.

Authors:  Shilpa Jain; Maria G Kapetanaki; Nalini Raghavachari; Kimberly Woodhouse; Guoying Yu; Suchitra Barge; Claudia Coronnello; Panayiotis V Benos; Gregory J Kato; Naftali Kaminski; Mark T Gladwin
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.